查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1268872

DNA聚合酵素市場規模,份額,趨勢分析報告,類型(Taq聚合酵素,Pfu聚合酵素,專有酵素混合物),應用,用途,地區,細分市場預測2023-2030

DNA Polymerase Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

DNA 聚合酵素市場增長和趨勢：

根據 Grand View Research, Inc. 的最新報告，全球 DNA 聚合酵素市場預計到 2030 年將達到 1.365 億美元。

預計從 2023 年到 2030 年，複合年增長率將達到 1.30%。 DNA 聚合酵素是參與生物體 DNA 複製和修復的必需酵素。 近年來，由於分子診斷、基因工程和藥物開發等各種應用對 DNA 聚合酵素的需求不斷增加，這些聚合酵素的市場經歷了顯著增長。 此外，這些聚合酵素在製藥、農業和法醫學等各個行業的使用越來越多，進一步推動了這一市場的擴張。

此外，遺傳病和癌症患病率上升也是推動市場增長的因素。 遺傳和罕見病 (GARD) 信息中心報告說，有 7,000 多種罕見病。 僅在美國，估計就有 25 至 3000 萬人患有罕見疾病，而且這個數字還在繼續增長。 此外，已知至少有20萬人是遺傳病的倖存者，英國每年有超過3萬名嬰兒和兒童被診斷出患有遺傳病，導致超過240萬人患有各種遺傳病。 預計這一趨勢將在預測期內持續，從而導致對 DNA 聚合酵素和相關產品的需求增加。

COVID-19 大流行增加了對診斷和治療藥物開發的需求，並且市場正在迅速擴大。 為了提高我們對病毒的理解並製定有效的檢測策略，研究人員和醫療保健從業者在各種分子診斷技術（如 PCR 和 RT-PCR）中使用 DNA 聚合酵素。 這種不斷增長的需求導致了市場的顯著擴張。 抗擊 COVID-19 的緊迫性正在推動科學創新和協作研究工作，以開發新的診斷工具和治療方法。 例如，生物技術公司 Ginkgo Bioworks 推出了 Concentric by Ginkgo，這是一項依賴 PCR 等基於 DNA 聚合酵素的技術的大規模 COVID-19 檢測服務。 這項工作證明了 DNA 聚合酵素在創新診斷解決方案中的作用。

新型 DNA 聚合酵素的開發具有增強的特性，例如高保真度、可加工性和對抑製劑的耐受性，擴大了它們的應用範圍。 這些進步使研究人員能夠進行更複雜的實驗並探索以前無法進入的基因組區域。 隨著對高效和準確的 DNA 聚合酵素的需求增加，這一領域的創新有望進一步推動市場。

此外，增加對個性化醫學研究的投資以及對其好處的認識不斷提高預計將在未來幾年推動市場發展。 例如，2020年12月，精準醫療科技公司騰邦科技獲得2億美元G-2輪融資，有效估值達到81億美元。 該公司計劃利用額外資金擴大業務並專注於一系列疾病，包括傳染病、憂鬱症和心臟病。 個性化醫療是一個新領域，旨在根據個人的基因構成提供個性化治療。 DNA 聚合酵素在個性化醫療必不可少的測序中發揮著重要作用。

DNA 聚合酵素市場報告亮點

  • 按類型劃分，Taq 聚合酵素細分市場在 2022 年以 53.99% 的份額佔據市場主導地位。 Taq 聚合酵素是 PCR 技術中常用的一種 DNA 聚合酵素。 隨著遺傳學和分子生物學研究的不斷擴大，對 PCR 的需求預計會增加，從而推動這一領域的增長。
  • 由於 DNA 擴增技術廣泛用於診斷和研究目的，聚合酵素鍊式反應部分在 2022 年的應用部分中佔有最大份額，達到 74.85%。
  • 由於遺傳病和傳染病（如 COVID-19）的流行率上升，導致基於聚合酵素的檢測方案的採用激增，到 2022 年，醫院和診斷中心部分將佔據 41.65% 的最大市場份額。佔據。
  • 北美在 2022 年佔據了 47.25% 的市場份額，在市場上確立了穩固的地位。 該地區是許多著名的生物技術和製藥公司的所在地，這些公司大力投資於新藥和治療的研發。

內容

第 1 章調查方法及範圍

  • 資訊採購
  • 資訊或數據分析
  • 市場範圍和細分定義
  • 市場模型
    • 按公司市場份額進行的市場調查
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場體系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 市場趨勢和前景
  • 市場動態
    • 市場促進因素
      • 越來越多地採用用於診斷和調查目的的測序技術
      • 在醫療保健領域更多地採用個性化醫療
      • 慢性病和傳染病的患病率增加
    • 市場抑制因素分析
      • 增加聚合酵素鏈反應技術的替代技術
      • 要求熟練的專業人員使用 PCR 和 NGS 技術
  • 商業環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特的五力分析
  • COVID-19 影響分析

第 4 章類型業務分析

  • DNA 聚合酵素市場：類型變異分析
  • Taq聚合酵素
  • Pfu聚合酵素
  • 原味酵素混合物
  • 其他

第 5 章應用業務分析

  • DNA 聚合酵素市場：應用變化分析
  • 聚合酵素鏈反應
  • DNA測序
  • DNA克隆
  • 其他

第 6 章最終用途業務分析

  • DNA 聚合酵素市場：最終用途的變化分析
  • 製藥和生物技術公司
  • 學術研究機構
  • 醫院和診斷中心
  • 其他

第 7 章區域業務分析

  • 2022 年和 2030 年各地區 DNA 聚合酵素市場份額
  • 北美
    • SWOT 分析
    • 美國
    • 加拿大
  • 歐洲
    • SWOT 分析
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT 分析
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • SWOT 分析
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • SWOT 分析
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc.
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Agilent Technologies
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Merck KGaA
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Danaher
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • QIAGEN
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Hoffmann-La Roche Ltd
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Bio-Rad Laboratories, Inc.;
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Takara Bio, Inc.
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • Promega Corporation
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
    • New England Biolabs
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利率）
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-059-4

DNA Polymerase Market Growth & Trends:

The global DNA polymerase market size is expected to reach USD 136.5 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 1.30% from 2023 to 2030. DNA polymerase are essential enzymes involved in the replication and repair of DNA in living organisms. These polymerases market has experienced significant growth in recent years due to the increasing demand for DNA polymerases in various applications, such as molecular diagnostics, genetic engineering, and drug development. Moreover, the increasing use of such polymerases in various industries, such as pharmaceuticals, agriculture, and forensics, has further fueled the expansion of this market.

In addition, rising prevalence of genetic disorders and cancers is another factor is driving the growth of the market. According to the Genetic and Rare Disease (GARD) Information Centre reports there are more than 7,000 rare diseases. In the U.S. alone, it is estimated that between 25 million and 30 million people are living with a rare disease, and this number continues to rise. Additionally, at least 200,000 people are known survivors of genetic disorders, while over 30,000 babies and children are diagnosed annually with genetic disorders in the UK, resulting in more than 2.4 million survivors of various genetic conditions. This trend is expected to continue over the forecast period, leading to a growing demand for DNA polymerase and related products.

The COVID-19 pandemic has led to an increased demand for diagnostics and therapeutic development, resulting in a surge in the market. To better understand the virus and develop effective testing strategies, researchers and healthcare professionals have relied on DNA polymerases for various molecular diagnostic techniques, such as PCR and RT-PCR. This increased demand has resulted in a significant expansion of the market. The urgency to combat COVID-19 has propelled scientific innovation and collaboration efforts to develop new diagnostic tools and therapies. For instance, Ginkgo Bioworks, a biotechnology company, has launched Concentric by Ginkgo, a large-scale COVID-19 testing service that depends on DNA polymerase-based techniques like PCR. This initiative showcases the role of DNA polymerases in innovative diagnostic solutions.

The development of novel DNA polymerase with enhanced properties, such as high fidelity, processivity, and resistance to inhibitors, has expanded their range of applications. These advancements have allowed researchers to conduct more complex experiments and explore previously inaccessible areas of the genome. As the demand for efficient and accurate DNA polymerases increases, innovations in this area are expected to boost the market further.

Furthermore, the growing investment in personalized medicine research and the rising awareness of its benefits are expected to drive the market in the coming years. For instance, in December 2020, Tempus, a precision medicine technology company, secured USD 200 million in Series G-2 funding, leading to a substantial valuation of USD 8.1 billion. The company plans to use the additional funding to expand its operations and focus on a range of diseases, including infectious diseases, depression, and cardiology. Personalized medicine is an emerging field that aims to provide tailored treatment options based on an individual's genetic makeup. DNA polymerase play a crucial role in sequencing, which is an essential component of personalized medicine.

DNA Polymerase Market Report Highlights:

  • By type, the Taq polymerase segment dominated the market with a share of 53.99% in 2022. Taq polymerases are a type of DNA polymerases that is commonly used in the PCR technique. As research in genetics and molecular biology continues to expand, the demand for PCR is expected to increase, driving the growth of this segment
  • The polymerase chain reaction segment accounted for the largest share of 74.85% in the application segment in 2022, due to the widespread use of the DNA amplification technique for diagnostic and research purposes
  • The hospitals and diagnostic centers segment accounted for the largest market share of 41.65% in 2022 due to the increasing prevalence of genetic disorders and infectious diseases like COVID-19 which led to a surge in the adoption of polymerase-based testing options
  • North America has established a strong regional position in the market with 47.25% share in 2022, which can be attributed to the high demand for biotechnology techniques. The region is home to numerous prominent biotech and pharmaceutical companies that invest heavily in research and development of new drugs and therapies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, by Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends And Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Market Drivers
      • 3.4.1.1. Increasing Adoption Of Sequencing Technologies For Diagnostic And Research Purposes
      • 3.4.1.2. Rising Adoption Of Personalized Medicine In Healthcare
      • 3.4.1.3. Increasing Prevalence Of Chronic And Infectious Diseases
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Increasing Number Of Alternatives To Polymerase Chain Reaction Technologies
      • 3.4.2.2. Requirement Of Skilled Professional For Handling PCR and NGS Technologies
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. DNA Polymerases Market: Type Movement Analysis
  • 4.2. Taq Polymerase
    • 4.2.1. Taq Polymerase Market, 2018 - 2030 (USD Million)
  • 4.3. Pfu Polymerase
    • 4.3.1. Pfu Polymerase Market, 2018 - 2030 (USD Million)
  • 4.4. Proprietary Enzyme Blends
    • 4.4.1. Proprietary Enzyme Blends Polymerase Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Other Types Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. DNA Polymerases Market: Application Movement Analysis
  • 5.2. Polymerase Chain Reaction
    • 5.2.1. Polymerase Chain Reaction Market, 2018 - 2030 (USD Million)
  • 5.3. DNA Sequencing
    • 5.3.1. DNA Sequencing Market, 2018 - 2030 (USD Million)
  • 5.4. DNA Cloning
    • 5.4.1. DNA Cloning Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. DNA Polymerases Market: End-Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Hospitals & Diagnostic Centers
    • 6.4.1. Hospitals & Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other End-uses Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. DNA Polymerases Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. U.S. DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Canada DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. UK DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. France DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Italy DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Spain DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Denmark DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Sweden DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Norway DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Japan DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. China DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. India DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. South Korea DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Australia DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Thailand DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Brazil DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Argentina DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. South Africa DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Saudi Arabia DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. UAE DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Kuwait DNA Polymerases Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Agilent Technologies
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Danaher
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. QIAGEN
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Hoffmann-La Roche Ltd
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Bio-Rad Laboratories, Inc.;
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Takara Bio, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Global DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 3 Global DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 4 Global DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 5 Global DNA polymerases market, by region, 2018 - 2030 (USD Million)
  • TABLE 6 North America DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 7 North America DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 8 North America DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 9 North America DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 13 Canada DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 14 Canada DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Canada DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 Europe DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 17 Europe DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 18 Europe DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 19 Europe DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 20 Germany DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 21 Germany DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 22 Germany DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 23 UK DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 24 UK DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 25 UK DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 26 France DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 27 France DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 28 France DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 29 Italy DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 30 Italy DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 31 Italy DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 32 Spain DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Spain DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 34 Spain DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 35 Denmark DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 36 Denmark DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 38 Sweden DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 39 Sweden DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 40 Sweden DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 41 Norway DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 42 Norway DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 43 Norway DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 48 China DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 49 China DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 50 China DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 51 Japan DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 52 Japan DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 53 Japan DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 54 India DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 55 India DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 56 India DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 57 South Korea DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 58 South Korea DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 60 Australia DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 61 Australia DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 62 Australia DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 63 Thailand DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 66 Latin America DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 70 Brazil DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 73 Mexico DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 76 Argentina DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 78 Argentina DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 79 Middle East & Africa DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 80 Middle East & Africa DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 81 Middle East & Africa DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 82 South Africa DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 83 South Africa DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Saudi Arabia DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 86 Saudi Arabia DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 87 Saudi Arabia DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 92 Kuwait DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait DNA polymerases market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 DNA polymerases market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Market penetration & growth prospect mapping, 2022
  • FIG. 15 Global DNA polymerases market: type movement analysis
  • FIG. 16 Global DNA polymerases market, for Taq polymerase, 2018 - 2030 (USD Million)
  • FIG. 17 Global DNA polymerases market, for Pfu polymerase, 2018 - 2030 (USD Million)
  • FIG. 18 Global DNA polymerases market, for proprietary enzyme blends, 2018 - 2030 (USD Million)
  • FIG. 19 Global DNA polymerases market, for other types, 2018 - 2030 (USD Million)
  • FIG. 20 Global DNA polymerases market: application movement analysis
  • FIG. 21 Global DNA polymerases market, for polymerase chain reaction, 2018 - 2030 (USD Million)
  • FIG. 22 Global DNA polymerases market, for DNA sequencing, 2018 - 2030 (USD Million)
  • FIG. 23 Global DNA polymerases market, for DNA cloning, 2018-030, (USD Million)
  • FIG. 24 Global DNA polymerases market, for other applications, 2018 - 2030 (USD Million)
  • FIG. 25 Global DNA polymerases market: end-use movement analysis
  • FIG. 26 Global DNA polymerases market, for pharmaceutical and biotechnology companies , 2018 - 2030 (USD Million)
  • FIG. 27 Global DNA polymerases market, for academic and research institute, 2018 - 2030 (USD Million)
  • FIG. 28 Global DNA polymerases market, for hospital and diagnostic centers, 2018 - 2030 (USD Million)
  • FIG. 29 Global DNA polymerases market, for other end-uses, 2018 - 2030 (USD Million)
  • FIG. 30 Regional marketplace: key takeaways
  • FIG. 31 Regional outlook, 2022 & 2030
  • FIG. 32 Global DNA polymerases market: region movement analysis
  • FIG. 33 North America DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 34 U.S. DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 35 Canada DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 36 Europe DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 37 Germany DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 38 UK DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 39 France DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 40 Italy DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 41 Spain DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 42 Denmark DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 43 Sweden DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 44 Norway DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 45 Asia Pacific DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 46 Japan DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 47 China DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 48 India DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 49 Australia DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 50 South Korea DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 51 Thailand DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 52 Latin America DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 53 Brazil DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 54 Mexico DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 55 Argentina DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 56 Middle East and Africa DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 57 South Africa DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 58 Saudi Arabia DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 59 UAE DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 60 Kuwait DNA polymerases market, 2018 - 2030 (USD Million)